7 unknown. 7 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 7 | Unknown 7 |
| Phase 2 | 1 | Unknown 1 |
Follow Streptococcal Infections: new trials by email Literature Review of Streptococcal Infections trials Research Report on Streptococcal Infections
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 3 Study to Evaluate the Immunogenicity and Safety of Walvax's PCV13-TT as Compared to Pfizer's PCV13 Walvax PCV13-TT, Pfizer PCV13 - Pneumococcal Disease, Invasive | Phase 3 | Unknown | Walvax Biotechnology Co., Ltd. | 630 | 2023-11-23 | 2024-07-03 |
| Dapagliflozin Effect on Rheumatic Mitral Stenosis Dapagliflozin - Rheumatic Heart Disease, Heart Failure | Phase 3 | Unknown | Universitas Sebelas Maret | 36 | 2022-12-01 | 2022-11-21 |
| Phase III Clinical Trial of 13-valent Pneumococcal Conjugate Vaccine (Multivalent Conjugate) in Infants 13-valent pneumococcal conjugate vaccine (multivalent conjugate), Prevenar 13 - Streptococcus Pneumoniae Infection | Phase 3 | Unknown | Fosun Adgenvax Biopharmaceutical Co.,Ltd. | 1800 | 2022-11-04 | 2024-10-01 |
| Immunogenicity and Safety Study of 15-Valent Pneumococcal Conjugate Vaccine in 2-month-old and 3-month-old Healthy Volunteers 15-Valent Pneumococcal Conjugate Vaccine, 13-Valent Pneumococcal Conjugate Vaccine - Pneumonia, Pneumococcal | Phase 3 | Unknown | Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | 1950 | 2020-07-01 | 2020-04-22 |
| The Effect of Ramipril in Suppressing ST2 Expression in Rheumatic Mitral Stenosis Patients Placebos, Ramipril 5Mg Oral Capsule - Rheumatic Heart Disease, Mitral Stenosis | Phase 3 | Unknown | Universitas Indonesia | 66 | 2019-06-27 | 2021-08-16 |
| Citriodiol® and Impetigo p-menthane-3,8-diol oil - Impetigo | Phase 2 / Phase 3 | Unknown | Royal North Shore Hospital | 30 | 2012-07-01 | 2012-06-20 |
| PneuMum: Pneumococcal Vaccination of Australian Indigenous Mothers to See if it Protects Their Babies From Ear Disease 23 valent pneumococcal polysaccharide vaccine - Middle Ear Effusion, Tympanic Membrane Perforation | Phase 3 | Unknown | University of Melbourne | 210 | 2006-03-01 | 2007-12-13 |
Pneumococcal Infections (3) · Mitral Valve Stenosis (2) · Rheumatic Heart Disease (2) · Fibrosis (1) · Heart Failure (1) · Impetigo (1) · Otitis Media (1) · Otitis Media with Effusion (1) · Pneumonia, Pneumococcal (1) · Tympanic Membrane Perforation (1)
Bacterial Infections (7) · Bacterial Infections and Mycoses (7) · Gram-Positive Bacterial Infections (7) · Infections (7) · Cardiovascular Diseases (2) · Heart Diseases (2) · Heart Valve Diseases (2) · Rheumatic Fever (2) · Ear Diseases (1) · Lung Diseases (1) · Otitis (1) · Otorhinolaryngologic Diseases (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
13-valent pneumococcal vaccine (1) · 23-valent pneumococcal capsular polysaccharide vaccine (1) · Control Groups (1) · Ramipril (1) · dapagliflozin (1) · terpin (1)
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd (1) · Fosun Adgenvax Biopharmaceutical Co.,Ltd. (1) · Royal North Shore Hospital (1) · Universitas Indonesia (1) · Universitas Sebelas Maret (1) · University of Melbourne (1) · Walvax Biotechnology Co., Ltd. (1)
Indonesia (3) · Australia (2) · China (2)
Ade Meidian Ambari, MD,FIHA (1) · Amanda J Leach, PhD (1) · An Aldia Asrial, MD (1) · Du Lin, Master (1) · Edward K Mulholland, DM (1) · Jonathan R Carapetis, PhD (1) · Peter S Morris, PhD (1) · Ross M Andrews, PhD (1)